Aegerion Pharmaceuticals Inc. (AEGR) reported third quarter adjusted EPS of $0.12 after the close Thursday, compared to the loss of $0.17 in the previous year. Analysts expected a loss of $0.14. Net product sales climbed to $43.67 million from $16.33 million. Analysts expected revenues of $48.64 million.
The company now expects to achieve between $150 million and $160 million of net product sales in 2014, revised from the previous expectation of the lower end of the $180 to $200 million range. Analysts currently expect revenues of $172.91 million.
Aegerion Pharmaceuticals has gapped open dramatically lower Friday morning and is now down 12.46 at $21.76 on above average volume. The stock has plunged to a new low for the year.
For comments and feedback contact: editorial@rttnews.com
Business News